120 related articles for article (PubMed ID: 29956857)
1. Raspberry bodies and hyaline globules with positive napsin A immunoexpression are useful features in diagnosing clear cell carcinoma of the female genital tract in cytology samples.
Rekhi B; Deodhar K; Gulia S; Bajpai J
Cytopathology; 2018 Dec; 29(6):600-602. PubMed ID: 29956857
[No Abstract] [Full Text] [Related]
2. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
[TBL] [Abstract][Full Text] [Related]
3. Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
Pors J; Segura S; Cheng A; Ji JX; Tessier-Cloutier B; Cochrane D; Fix DJ; Park K; Gilks B; Hoang L
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):593-601. PubMed ID: 31361605
[TBL] [Abstract][Full Text] [Related]
4. Napsin-A, a Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Alshenawy HA; Radi DA
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):605-610. PubMed ID: 28362708
[TBL] [Abstract][Full Text] [Related]
5. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
6. Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas.
Talia KL; Wong RW; McCluggage WG
Int J Gynecol Pathol; 2019 May; 38(3):276-282. PubMed ID: 29901522
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W
Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401
[TBL] [Abstract][Full Text] [Related]
8. Napsin A as a marker of clear cell ovarian carcinoma.
Skirnisdottir I; Bjersand K; Akerud H; Seidal T
BMC Cancer; 2013 Nov; 13():524. PubMed ID: 24191930
[TBL] [Abstract][Full Text] [Related]
9. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
[TBL] [Abstract][Full Text] [Related]
11. Napsin A: Another milestone in the subclassification of ovarian carcinoma.
Köbel M; Duggan MA
Am J Clin Pathol; 2014 Dec; 142(6):735-7. PubMed ID: 25389324
[No Abstract] [Full Text] [Related]
12. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
[TBL] [Abstract][Full Text] [Related]
13. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
14. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Kandalaft PL; Gown AM; Isacson C
Am J Clin Pathol; 2014 Dec; 142(6):830-6. PubMed ID: 25389337
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
[TBL] [Abstract][Full Text] [Related]
16. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
Ju B; Wang J; Yang B; Sun L; Guo Y; Hao Q; Wu J
Int J Gynecol Pathol; 2018 Jul; 37(4):388-396. PubMed ID: 28796747
[TBL] [Abstract][Full Text] [Related]
17. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
[TBL] [Abstract][Full Text] [Related]
18. Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Yamashita Y; Nagasaka T; Naiki-Ito A; Sato S; Suzuki S; Toyokuni S; Ito M; Takahashi S
Mod Pathol; 2015 Jan; 28(1):111-7. PubMed ID: 24721826
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic role of immunohistochemical expression of napsin-A aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233 primary and metastatic cases.
Xu B; Abourbih S; Sircar K; Kassouf W; Aprikian A; Tanguay S; Brimo F
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):206-12. PubMed ID: 23702650
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
Kato N; Toukairin M; Asanuma I; Motoyama T
Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
